Application of combined omics platforms to accelerate biomedical discovery in diabesity

Irwin J. Kurland, Domenico Accili, Charles Burant, Steven M. Fischer, Barbara B. Kahn, Christopher B. Newgard, Suma Ramagiri, Gabriele V. Ronnett, John A. Ryals, Mark Sanders, Joe Shambaugh, John Shockcor, Steven S. Gross

Research output: Contribution to journalArticle

Abstract

Diabesity has become a popular term to describe the specific form of diabetes that develops late in life and is associated with obesity. While there is a correlation between diabetes and obesity, the association is not universally predictive. Defining the metabolic characteristics of obesity that lead to diabetes, and how obese individuals who develop diabetes different from those who do not, are important goals. The use of large-scale omics analyses (e.g., metabolomic, proteomic, transcriptomic, and lipidomic) of diabetes and obesity may help to identify new targets to treat these conditions. This report discusses how various types of omics data can be integrated to shed light on the changes in metabolism that occur in obesity and diabetes.

Original languageEnglish (US)
Pages (from-to)1-16
Number of pages16
JournalAnnals of the New York Academy of Sciences
Volume1287
Issue number1
DOIs
StatePublished - May 2013

Fingerprint

Medical problems
Obesity
Metabolomics
Proteomics
Metabolism
Diabetes

Keywords

  • Diabesity
  • Diabetes
  • Lipidomics
  • Metabolism, metabolic profiling
  • Metabolomics
  • Obesity
  • Omics
  • Proteomics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Kurland, I. J., Accili, D., Burant, C., Fischer, S. M., Kahn, B. B., Newgard, C. B., ... Gross, S. S. (2013). Application of combined omics platforms to accelerate biomedical discovery in diabesity. Annals of the New York Academy of Sciences, 1287(1), 1-16. https://doi.org/10.1111/nyas.12116

Application of combined omics platforms to accelerate biomedical discovery in diabesity. / Kurland, Irwin J.; Accili, Domenico; Burant, Charles; Fischer, Steven M.; Kahn, Barbara B.; Newgard, Christopher B.; Ramagiri, Suma; Ronnett, Gabriele V.; Ryals, John A.; Sanders, Mark; Shambaugh, Joe; Shockcor, John; Gross, Steven S.

In: Annals of the New York Academy of Sciences, Vol. 1287, No. 1, 05.2013, p. 1-16.

Research output: Contribution to journalArticle

Kurland, IJ, Accili, D, Burant, C, Fischer, SM, Kahn, BB, Newgard, CB, Ramagiri, S, Ronnett, GV, Ryals, JA, Sanders, M, Shambaugh, J, Shockcor, J & Gross, SS 2013, 'Application of combined omics platforms to accelerate biomedical discovery in diabesity', Annals of the New York Academy of Sciences, vol. 1287, no. 1, pp. 1-16. https://doi.org/10.1111/nyas.12116
Kurland, Irwin J. ; Accili, Domenico ; Burant, Charles ; Fischer, Steven M. ; Kahn, Barbara B. ; Newgard, Christopher B. ; Ramagiri, Suma ; Ronnett, Gabriele V. ; Ryals, John A. ; Sanders, Mark ; Shambaugh, Joe ; Shockcor, John ; Gross, Steven S. / Application of combined omics platforms to accelerate biomedical discovery in diabesity. In: Annals of the New York Academy of Sciences. 2013 ; Vol. 1287, No. 1. pp. 1-16.
@article{edee447668fa4fe7ac1af766728437b7,
title = "Application of combined omics platforms to accelerate biomedical discovery in diabesity",
abstract = "Diabesity has become a popular term to describe the specific form of diabetes that develops late in life and is associated with obesity. While there is a correlation between diabetes and obesity, the association is not universally predictive. Defining the metabolic characteristics of obesity that lead to diabetes, and how obese individuals who develop diabetes different from those who do not, are important goals. The use of large-scale omics analyses (e.g., metabolomic, proteomic, transcriptomic, and lipidomic) of diabetes and obesity may help to identify new targets to treat these conditions. This report discusses how various types of omics data can be integrated to shed light on the changes in metabolism that occur in obesity and diabetes.",
keywords = "Diabesity, Diabetes, Lipidomics, Metabolism, metabolic profiling, Metabolomics, Obesity, Omics, Proteomics",
author = "Kurland, {Irwin J.} and Domenico Accili and Charles Burant and Fischer, {Steven M.} and Kahn, {Barbara B.} and Newgard, {Christopher B.} and Suma Ramagiri and Ronnett, {Gabriele V.} and Ryals, {John A.} and Mark Sanders and Joe Shambaugh and John Shockcor and Gross, {Steven S.}",
year = "2013",
month = "5",
doi = "10.1111/nyas.12116",
language = "English (US)",
volume = "1287",
pages = "1--16",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Application of combined omics platforms to accelerate biomedical discovery in diabesity

AU - Kurland, Irwin J.

AU - Accili, Domenico

AU - Burant, Charles

AU - Fischer, Steven M.

AU - Kahn, Barbara B.

AU - Newgard, Christopher B.

AU - Ramagiri, Suma

AU - Ronnett, Gabriele V.

AU - Ryals, John A.

AU - Sanders, Mark

AU - Shambaugh, Joe

AU - Shockcor, John

AU - Gross, Steven S.

PY - 2013/5

Y1 - 2013/5

N2 - Diabesity has become a popular term to describe the specific form of diabetes that develops late in life and is associated with obesity. While there is a correlation between diabetes and obesity, the association is not universally predictive. Defining the metabolic characteristics of obesity that lead to diabetes, and how obese individuals who develop diabetes different from those who do not, are important goals. The use of large-scale omics analyses (e.g., metabolomic, proteomic, transcriptomic, and lipidomic) of diabetes and obesity may help to identify new targets to treat these conditions. This report discusses how various types of omics data can be integrated to shed light on the changes in metabolism that occur in obesity and diabetes.

AB - Diabesity has become a popular term to describe the specific form of diabetes that develops late in life and is associated with obesity. While there is a correlation between diabetes and obesity, the association is not universally predictive. Defining the metabolic characteristics of obesity that lead to diabetes, and how obese individuals who develop diabetes different from those who do not, are important goals. The use of large-scale omics analyses (e.g., metabolomic, proteomic, transcriptomic, and lipidomic) of diabetes and obesity may help to identify new targets to treat these conditions. This report discusses how various types of omics data can be integrated to shed light on the changes in metabolism that occur in obesity and diabetes.

KW - Diabesity

KW - Diabetes

KW - Lipidomics

KW - Metabolism, metabolic profiling

KW - Metabolomics

KW - Obesity

KW - Omics

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=84878437983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878437983&partnerID=8YFLogxK

U2 - 10.1111/nyas.12116

DO - 10.1111/nyas.12116

M3 - Article

C2 - 23659636

AN - SCOPUS:84878437983

VL - 1287

SP - 1

EP - 16

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -